Journal article
Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous population
KS Ong, R Carter, T Vos, M Kelaher, I Anderson
Heart Lung and Circulation | Published : 2014
Abstract
Background: Cardiovascular disease is the leading cause of disease burden in Australia's Indigenous population, and the greatest contributor to the Indigenous 'health gap'. Economic evidence can help identify interventions that efficiently address this discrepancy. Methods: Five interventions (one community-based and four pharmacological) to prevent cardiovascular disease in Australia's Indigenous population were subject to economic evaluation. Pharmacological interventions were evaluated as delivered either via Aboriginal Community Controlled Health Services or mainstream general practitioner services. Cost-utility analysis methods were used, with health benefit measured in disability-adjus..
View full abstractGrants
Funding Acknowledgements
This research, as part of the Assessing Cost Effectiveness Prevention (ACE-Prevention) project, was funded by the National Health and Medical Research Council (NHMRC) of Australia. Additional funding for Project Steering Committee meetings, data collection and writing of the manuscript was provided by the Lowitja Institute, Australia's National Institute for Aboriginal and Torres Strait Islander Health Research. A postgraduate research scholarship was provided by the University of Melbourne. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.